IMSCO INC /MA/
8-K, 1999-04-01
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: CHS ELECTRONICS INC, 10-Q/A, 1999-04-01
Next: SMITH MIDLAND CORP, NT 10-K, 1999-04-01



                       SECURITIES AND EXCHANGE COMMISSION


                              Washington, DC 20549


                                    FORM 8-K


                                 CURRENT REPORT





     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934





         Date of Report (Date of earliest event reported): April 1, 1999



                            IMSCO TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its charter)


           Delaware                   02-24520               04-3021770
(State or other jurisdiction         (Commission          (IRS Employer
of incorporation)                     File No.)           Identification Number)


                   40 Bayfield Drive, North Andover, MA 01845
             (Address of principal executive offices and zip code)


       Registrant's telephone number, including area code: (978) 689-2080


                                       N/A
          (Former name or former address, if changed since last report)



                                     1 of 3
<PAGE>


Item 5.  Other Events
- -------  ------------

          On March 22, 1999, IMSCO Technologies,  Inc. (the "Company") appointed
Timothy J. Keating to fill a vacancy on the Company's  Board of Directors.  In a
related  management  move,  the  Company  removed Sol Berg as  president  of the
Company.  The  additional  information  contained  in  Exhibit  20.1  hereto  is
incorporated herein by reference.

Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits
- -------  ------------------------------------------------------------------

        (c)    Exhibits

               Exhibit No.                  Description
               -----------                  -----------

               20.1                         Press Release, dated March 29, 1999



                                     2 of 3
<PAGE>


                                   SIGNATURES

          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                         IMSCO TECHNOLOGIES, INC.


Date: April    , 1999                    By:                                    
            ---                             ------------------------------------
                                            Alexander T. Hoffman
                                            Chairman and Chief Executive Officer




                                     3 of 3



                                                                   Exhibit 20.1
                                                                   ------------

IMSCO Technologies Inc. announces New Director, Management Change.

North Andover,  MA, March 29 - IMSCO  Technologies Inc.  (NASDQ/Bulletin  Board;
IMSO, "the Company"),  announced today the appointment of Mr. Timothy J. Keating
to fill a  vacancy  on the  Board  of  Directors.  Mr.  Keating  is a  respected
financial  professional  with a record of  success in the  development  of early
stage companies.  A graduate of Harvard College, Mr. Keating founded and ran the
European Equity Derivative Products  Department for Nomura  International plc in
London,  was a  proprietary  arbitrage  trader and head of the  European  Equity
Trading  Department at Bear Stearns  International  Limited,  London and for the
past two years was a principal  and portfolio  manager in a private  partnership
investing in microcap companies.

In a related  development,  IMSCO  announced  that Sol Berg has been  removed as
president  of the  Company.  Mr.  Alexander  Hoffmann,  Chairman  & CEO of IMSCO
stated,  "management  and the Board of Directors of IMSCO feel that it is in the
best interest of the Company and its  shareholders to contract the operations of
the North Andover office and move the development and commercialization  efforts
for its  patented  "Decaffeinator  Basket"  to the  facilities  of the Arthur D.
Little Company in Cambridge, Massachusetts".

The  Arthur  D.  Little  Company  has  offices  in  over 30  countries  offering
Management  Consulting,  Technology and Product  Innovation  and  Environmental,
Health and Safety Consulting.

IMSCO  Technologies  Inc.  is a  Separation  Technology  Company  based in North
Andover,  Massachusetts that has developed a patented,  proprietary process that
decaffeinates  brewed coffee on demand.  In addition,  the IMSCO Process has the
potential to improve the  effectiveness,  accuracy and speed of blood tests, the
separation  of  viral  DNA  and  RNA  from  blood  and  blood  products,   water
purification and desalination,  purification of essence in the perfume industry,
purification  of  flavors  and  protein   purification  for  the  pharmaceutical
industry.

This press release contains  forward-looking  statements which are made pursuant
to the safe-harbor provisions of the Private Securities Litigation Reform Act of
1995.  Expressions  of future goals and similar  expressions  including  without
limitation  "believes",  "should",  "hope",  "expects",  "expected",  "does  not
currently expect",  and "forecast",  reflecting  something other than historical
fact  are  intended  to  identify  forward-looking  statements,  but are not the
exclusive means of identifying such statements. These forward-looking statements
involve a number of risks and  uncertainties,  including the timely  development
and market  acceptance of products and technologies and other factors  described
in the Company's filing with the Securities and Exchange Commission.  The actual
results may differ  materially from any  forward-looking  statements due to such
risks and  uncertainties.  The Company  undertakes no  obligations  to revise or
update  any   forward-looking   statements   in  order  to  reflect   events  or
circumstances that may arise after the date of this release.

For further information contact:
John McGill
Shannon Partners
(860) 739-8967



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission